Md. Toukir Imam

Learn More
This challenge attempts to improve the prediction of survival and toxicity of docetaxel treatment in patients with metastatic castrate-resistant prostate cancer (mCRPC). Our team attempted to build survival models using machine learning techniques for the challenge. Our team PC-LEARN, is one of the winners of the sub-challenge two and was placed 5th in the(More)
  • 1